In context
BPC-157 has been investigated in laboratory and animal injury models. Small uncontrolled human reports do not establish that it safely or effectively treats injuries in people. [1–2]
At a glance
- Type
- Experimental peptide
- Regulatory context
- Experimental evidence must not be confused with authorisation of a particular product. This guide does not establish Thai marketing authorisation.
- Evidence
- A rat tendon study and a small retrospective knee-pain report answer different questions. Neither establishes broad clinical efficacy or long-term safety.
What has been studied?
An original study examined tendon repair in rats and effects on cultured cells. Those results are preclinical: injury models and laboratory observations cannot be assumed to predict clinical benefit. [1] [2]
What human data can tell us
A retrospective knee-pain report followed a small group by telephone and included some combination use. There was no randomised control group, and standardised functional outcomes were not collected. These limitations prevent a reliable treatment-effect estimate. [1] [2]
Safety and clinical context
Human safety information is limited. Findings from animals, small uncontrolled studies or marketed research materials cannot establish an individual's treatment safety.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Related treatment information
A library entry is not a prescribing recommendation. Our treatment pages explain the assessment and doctor-review process.
Read treatment informationPrimary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.
- Rat Achilles-tendon and cell study (2003) pubmed.ncbi.nlm.nih.gov
- Retrospective knee-pain report (2021) pubmed.ncbi.nlm.nih.gov